Additional Resources

Additional Resources Related to Opioid Use and Opioid Use Disorder

As this is a living resource, the three partnering organizations recognize that content reflected here may require updating as new evidence emerges.

Many of the following resources appear in the modules, this list has been compiled for quick reference.

• Canadian Association for Mental Health: Preventing opioid overdose
• Canadian Centre for Addictions: Systemic Racism & Addiction: How are They Connected?
• Centre for Addiction and Mental Health: Methadone Maintenance Treatment: Client handbook revised
• Centre for Effective Practice: Management of Chronic Non-Cancer Pain
• Choosing Wisely Canada: Opioids – When you need them and when you don’t
• EQUIP Healthcare: An overview of a multi-component intervention to enhance equity-oriented care in primary health care settings
• Government of Canada: Awareness resources for opioids
• Government of Canada: Opioid and Stimulated related Harms in Canada
• Government of Canada: Opioids and the opioid crisis – Get the facts
• Institute for Safe Medication Practices Canada: Opioid Pain Medicines Information for Patients and Families
• Institute for Safe Medication Practices Canada: Opioids for Pain After Surgery: Your Questions Answered

Substance use and COVID-19:

The current climate has had a significant impact on persons using drugs. The following resources are related to the effect COVID-19 has had on opioid use in Canada.

• Canadian Centre on Substance Use and Addiction: Impacts of the COVID-19 on Substance Use
• Centre for Addiction and Mental Health: Early Guidance for Pharmacists in Managing Opioid Agonist Treatment during the COVID-19 Pandemic
  • This document specifically refers to pharmacists’ practice as it relates to buprenorphine and methadone as opioid agonist treatments (OAT).
• Government of Canada: Helping people who use substances during the COVID-19 pandemic
• Government of Canada: Modelling opioid overdose deaths during the COVID-19 outbreak
• Applying the lessons of COVID-19 response to Canada’s worsening opioid pandemic. Alexa Norton & Thomas Kerr. The Lancet, Vol.29 https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30377-1/fulltext